EW Technical Analysis



As of date:4/15/2024
EW stock price:89.20
EW 50 DMA:89.88
EW 200 DMA:78.85
EW MACD (200-50):-11.03
EW RSI:35.11
Extremely
Overbought
Overbought/Oversold RSI Range
RSI Indicator (Relative Strength Index)35.11
Extremely
Oversold

Also see:
EW Market Cap History
EW Shares Outstanding History
EW YTD Return

Quotes delayed 20 minutes

Email EnvelopeFree EW Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

ITOS Crosses Below Key Moving Average Level
1 hour, 14 minutes ago


Notable Two Hundred Day Moving Average Cross - HYLS
1 hour, 32 minutes ago


BTU Crosses Above Key Moving Average Level
1 hour, 32 minutes ago


First Capital Real Estate Investment Trust Breaks Below 200-Day Moving Average - Notable for FCR.UN.CA
1 hour, 35 minutes ago


Notable Two Hundred Day Moving Average Cross - D
1 hour, 35 minutes ago


PPL Shares Cross Below 200 DMA
1 hour, 35 minutes ago


Shares of DRQ Now Oversold
1 hour, 35 minutes ago


IMAX Breaks Above 200-Day Moving Average - Bullish for IMAX
1 hour, 37 minutes ago


HYDW Crosses Critical Technical Indicator
1 hour, 37 minutes ago


Shares of VRP Now Oversold
1 hour, 37 minutes ago


JNK Makes Notable Cross Below Critical Moving Average
1 hour, 37 minutes ago


Corning Breaks Below 200-Day Moving Average - Notable for GLW
1 hour, 37 minutes ago


CSTL Makes Notable Cross Below Critical Moving Average
3 hours, 34 minutes ago


DuPont Breaks Below 200-Day Moving Average - Notable for DD
3 hours, 35 minutes ago


FHTX Makes Notable Cross Below Critical Moving Average
3 hours, 37 minutes ago


More Technical Analysis News

EW Technical AnalysisEW RSI
Edwards Lifesciences is focused on technologies that treat structural heart disease and ill patients. The products and technologies provided by Co. are categorized into the following main areas: Transcatheter Aortic Valve Replacement, which is engaged in transcatheter heart valve replacement technologies; Transcatheter Mitral and Tricuspid Therapies, which is focused on the development of transcatheter heart valve repair and replacement technologies designed to treat mitral and tricuspid valve diseases; Surgical Structural Heart, which is engaged in cardiac surgical therapies; and Critical Care, which is engaged in hemodynamic monitoring systems.

When researching a stock like Edwards Lifesciences, many investors are the most familiar with Fundamental Analysis — looking at a company's balance sheet, earnings, revenues, and what's happening in that company's underlying business. Investors who use Fundamental Analysis to identify good stocks to buy or sell can also benefit from EW Technical Analysis to help find a good entry or exit point. Technical Analysis is blind to the fundamentals and looks only at the trading data for EW stock — the real life supply and demand for the stock over time — and examines that data in different ways.
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks

10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
EW DMAEW MACD
Video: Technical Analysis


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Edwards Lifesciences (EW) is categorized under the Healthcare sector; to help you further research Technical Analysis, below are some other companies in the same sector:

GEHC Technical Analysis
GILD Technical Analysis
HCA Technical Analysis
HOLX Technical Analysis
HSIC Technical Analysis
IDXX Technical Analysis
ILMN Technical Analysis
INCY Technical Analysis
IQV Technical Analysis
ISRG Technical Analysis
More Healthcare companies »

 

EW Technical Analysis | www.TechnicalAnalysisChannel.com | Copyright © 2019 - 2024, All Rights Reserved

Nothing in TechnicalAnalysisChannel.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.